ANL
Adlai Nortye Ltd.
NASDAQ · Healthcare · Biotechnology · KY
$9.61
+0.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 20.99x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.88x
- Price / sales
- 31.45x
- Price / cash flow
- -10.68x
Enterprise value
- Enterprise value
- $412.7M
- EV / sales
- 20.97x
- EV / EBITDA
- -19.64x
- EV / EBIT
- -18.51x
- Market cap
- $618.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026